Results 21 to 30 of about 31,301 (226)
Amlodipine reduces AngII-induced aortic aneurysms and atherosclerosis in hypercholesterolemic mice. [PDF]
PLoS ONE, 2013 The purpose of this study was to determine effects of amlodipine, a dihydropyridine calcium channel blocker, on development of angiotensin II (AngII)-induced vascular pathologies.Male LDL receptor -/- mice were infused with vehicle, amlodipine (5 mg/kg/d)
Xiaofeng Chen +8 more
doaj +1 more source
CURRENT ANALYTICAL METHODS FOR AMLODIPINE AND ITS FORMULATIONS: A REVIEW [PDF]
Journal CleanWAS, 2017 The use of amlodipine is very common due to the effects of amlodipine on hypertension and coronary artery disease (CAD) like chronic stable angina, vasospastic angina (Prinzmetal’s or variant angina), and angiographically documented CAD.
A.b. M. Helal +5 more
doaj +1 more source
Clinical and Experimental Hypertension, 2023 Objectives To investigate the actions of amlodipine-folic acid (amlodipine-FA) preparation on hypertension and cardiovascular in renal hypertensive rats with hyperhomocysteinemia (HHcy), so as to provide experimental basis for clinical research of ...
Li Li +5 more
doaj +1 more source
Drugs - Real World Outcomes, 2020 Background The effectiveness of amlodipine has been reported in clinical trials in India. However, real-world data on the effectiveness of amlodipine in India is limited.
Mohammed Yunus Khan +8 more
doaj +1 more source
Modern views on amlodipine and new S-amlodipine medications
Кардиоваскулярная терапия и профилактика, 2011 The review presents the latest evidence on the calcium antagonist amlodipine, summarizing its mechanisms of action, its pleiotropic, endothelial function-related effects, and its anti-atherogenic activity.
M. V. Leonova
doaj +1 more source
Рациональная фармакотерапия в кардиологии, 2015 Aim. To study efficacy and safety of calcium channel blocker, S-amlodipine, in combination with β-blocker, atenolol, in patients with arterial hypertension (HT) 1-2 degree com- pared to fixed combination of racemic amlodipine and atenolol.Material and ...
M. A. Maksimova +2 more
doaj +3 more sources
The Breast, 2001 We report only the second published confirmed case of gynaecomastia caused by amlodipine (a dihydropyridine calcium channel blocker). Gynaecomastia developed in a 70-year-old male within 3 months of starting amlodipine, and symptoms resolved within 3 weeks of drug withdrawal suggesting a strong relationship between amlodipine and gynaecomastia in this ...
P G, Cornes, A C, Hole
openaire +2 more sources
Eurasian Journal of Medicine, 2019 Objective: The aim of this study was to determine the potential, protective effects of amlodipine in an experimental, ischemia-reperfusion (I/R) model in the rabbit small intestine.
A. Kagan Coskun +9 more
doaj +1 more source
National Journal of Physiology, Pharmacy and Pharmacology, 2014 Background: The development of newer classes of antiepileptic drugs has created several opportunities for the treatment of epilepsy. Aims & Objective: The present study was designed to assess the$effect of amlodipine on the antiepileptic action of ...
Mohamed Abdelgalil Hassan +1 more
doaj +1 more source
Safety of combination therapy of azilsartan medoxomil and amlodipine: a population-based cohort study [PDF]
Epidemiology and HealthOBJECTIVES This study investigated the safety of azilsartan and amlodipine combination therapy versus other angiotensin receptor blockers (ARBs) and amlodipine in patients with hypertension.
Hyesung Lee +9 more
doaj +1 more source